Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 9,838 | 8,677 | 7,476 | 6,838 | 5,594 |
| Cost of Goods | 4,168 | 3,966 | 3,607 | 3,471 | 3,132 |
| Gross Profit | 5,670 | 4,711 | 3,869 | 3,367 | 2,462 |
| Operating Expenses | 13,649 | 12,238 | 11,051 | 9,600 | 8,695 |
| Operating Income | -7,811 | -6,561 | -6,575 | -5,762 | -6,101 |
| Interest Expense | 114 | 113 | 111 | 102 | 126 |
| Other Income | 23 | 19 | 12 | -28 | -76 |
| Pre-tax Income | -7,902 | -6,655 | -6,674 | -5,892 | -6,303 |
| Net Income Continuous | -7,902 | -6,655 | -6,674 | -5,892 | -6,303 |
| Net Income | $-7,902 | $-6,655 | $-6,674 | $-5,892 | $-6,303 |
| EPS Basic Total Ops | -0.37 | -0.31 | -0.32 | 17.01 | -6.59 |
| EPS Basic Continuous Ops | -0.37 | -0.31 | -0.32 | 17.01 | -6.59 |
| EPS Diluted Total Ops | -0.37 | -0.31 | -0.32 | 17.01 | -6.59 |
| EPS Diluted Continuous Ops | -0.37 | -0.31 | -0.32 | 17.01 | -6.59 |
| EBITDA(a) | $-8,036 | $-6,881 | $-6,910 | $-6,077 | $-6,411 |